SCHEMBL7013077

SCHEMBL7013077

c1ccc(COc2cccn3cccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.52
MAPK1 P28482 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
HTR1A P08908 3/20 0.49
DRD2 P14416 1/20 0.49
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
LIPE Q05469 1/20 0.47
MAPK14 Q16539 5/20 0.46
LTA4H P09960 1/20 0.46
ATP4A P20648 2/20 0.46
ATP4B P51164 2/20 0.46
ALPG P10696 1/20 0.45
PTK2B Q14289 1/20 0.45
BRD4 O60885 1/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CDK4 P11802 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931637 0.80 MAPK1 (0.44) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL7008271 0.79 MAPK1 (0.50) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL7012495 0.78 MAPK1 (0.45) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL339812 0.77 MAPT (0.71) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL6535132 0.77 ABCB1 (0.48) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL9198538 0.76 LTA4H (0.49) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL183867 0.76 ATP4A (0.51) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL9772804 0.76 ATP4A (0.50) MAPTMAPK1L3MBTL1SLC6A4MAPK14
SCHEMBL7011291 0.75 HTR1A (0.43) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL19044207 0.74 MAPK1 (0.44) MAPTMAPK1TDP1L3MBTL1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed